Undiagnosed Depression in Post Acute Care: A Clinical AI Platform

Why is **undiagnosed depression post acute care** such a pervasive problem? In post-acute care, depression is missed in up to 75% of cases, impacting patient well-being, outcomes, and facility finances. Missed diagnoses mean untreated symptoms, leading to a cycle of decline.

What Are the Hidden Costs of Undiagnosed Depression Post Acute Care?

The costs of **undiagnosed depression post acute care** extend far beyond individual patient suffering. Undetected and untreated depression directly impacts your facility's financial health and operational efficiency. Depression increases the likelihood of hospital readmissions. That hurts your Medicare star rating. It also complicates care plans, demanding more staff time and resources. A negative reputation spreads quickly, affecting census and referral rates. This is a loss aversion issue. Imagine the financial impact of preventing just a handful of avoidable readmissions each month. GIA™ offers an effective way to identify depression early. She screens in under 5 minutes, providing results in 60 seconds. Clinicians review and approve all screening results, supplementing their expertise with AI-powered insights. The platform is 510(k) registered and HIPAA compliant.

Why do traditional depression screening methods fail in post-acute care?

Traditional methods often fall short in the demanding environment of **post-acute care**. Reliance on manual assessments, like the Post-acute Depression Scale, is time-consuming and subject to human variability. Staff may lack specialized training in mental health screening. High patient loads and staffing shortages further limit the ability to conduct thorough evaluations. Cognitive impairment among residents can also hinder accurate self-reporting. These challenges contribute to the high rate of undiagnosed depression, leaving many residents without the care they need. GIA™ addresses these shortcomings. She uses speech biomarkers and visual data points from a brief conversation to screen for depression with 81.6% accuracy. This supplements existing clinical judgment without adding burden.

How Does Clinical AI Improve Depression Detection Rates in Post Acute Care?

**Clinical AI** offers a standardized, objective approach to **depression screening** in **post acute care**. GIA™ analyzes over 2,500 speech biomarkers and 436 visual data points during a brief interaction with a resident. Her screening process takes under 5 minutes. Results are available in 60 seconds. This allows for more frequent and consistent screening, identifying potential cases that might otherwise be missed. GIA™ integrates with major EHR systems like major EHR systems. This ensures smooth data transfer and improved care coordination. Remember that GIA™ does not diagnose. A clinician reviews and approves all screening results. GIA™ flags residents who may benefit from further evaluation, allowing clinicians to focus their time and expertise where it's needed most. The system has access to 12.3M longitudinal PAC/LTC patient records and 27B clinical events. This is powered by digitalhumanOS™.

What ROI can facilities expect from clinical AI screening for undiagnosed depression?

The return on investment extends beyond direct cost savings from reduced readmissions. Early detection of **undiagnosed depression** improves resident well-being. This leads to better engagement in therapy, enhanced rehabilitation outcomes, and improved overall quality of life. Positive outcomes contribute to a better reputation for your facility. That attracts more referrals and improves census. Standardizing screening across your portfolio, if you're a if you're a regional operator, can streamline clinical operations. GIA™ is bundled on Samsung Health Grade Galaxy devices with Samsung Knox, offering a secure and convenient screening experience. GIA™ speaks 92 languages, improving patient comfort and engagement during screening. Consider the long-term benefits of a preventative approach to mental health. It's an investment in your residents, your staff, and the financial health of your facility.

Conclusion

Ignoring **undiagnosed depression post acute care** is no longer a sustainable strategy. It harms residents, strains resources, and impacts your bottom line. **Clinical AI** screening provides an effective way to proactively identify and address mental health needs. Are you ready to take the first step toward improving the lives of your residents and the financial health of your facility?